SUMMARY IgG class antibodies reactive with myelin basic protein (MBP) were determined by enzyme-linked immunosorbent assay (ELISA) in serum and cerebrospinal fluid (CSF) of 37 patients with multiple sclerosis and a control group of 32 patients with tension headache or psychoneurosis. Using standardised amounts of IgG from CSF and serum in ELISA, significantly higher mean antibody levels were found in CSF as well as in serum from the patients with multiple sclerosis. Ten (27%) of the multiple sclerosis CSF samples and 15 (41 %) of the multiple sclerosis sera revealed anti MBP antibody levels exceeding 2 SD of the control group. Seven patients (19%) showed exclusive or higher levels of anti MBP antibodies in CSF, suggesting synthesis within the central nervous system. Analysis by ELISA for IgG subclasses of anti MBP antibodies revealed that they were restricted to IgG 1 in four patients and IgG 3 in one.
Immunoglobulin aberrations especially of the cerebrospinal fluid (CSF) are important characteristics of multiple sclerosis.1 2 The biological significance of the CSF IgG and its antigenic specificity are largely unknown.
Since the identification of myelin basic protein (MBP) gg/ml, and incubated 2 h at 37°C; (2) rabbit anti-human IgG, gamma-chains specific (Dakopatts, Copenhagen, Denmark), diluted 1:4000 and kept over night at room temperature; (3) alkaline phosphatase conjugated goat anti-rabbit IgG (Miles-Yeda Ltd, Israel), diluted 1:2500, and incubated for 4 h at room temperature. Samples and antisera were diluted in 0 01 M phosphate buffer pH 7 0, containing 1% BSA, 1-2% NaC1, 0 5% Tween 80, and 0-1% histones. After addition of substrate (disodium p-nitro-phenylphosphate from Sigma, I mg/ml in 10% diethanolamine buffer, pH 9-8) the 
Results
Routine studies of CSF and serum revealed that all except three of the 37 patients with multiple sclerosis had increased CSF IgG index, and all but one had oligoclonal IgG bands. All 32 patients in the control group were negative in these respects.
ELISA for detection of antibodies reactive with MBP revealed a significantly higher (p < 0-01; MannWhitney's U contrast test) mean value in the CSF of multiple sclerosis patients compared with controls ( Fig. 1) . Ten of the 37 multiple sclerosis patients (27%) had values in CSF exceeding 2 SD of the controls. In sera, the mean value of anti MBP antibodies was also higher for multiple sclerosis patients than controls (p < 0-01) (fig The site of production of anti MBP antibodies is controversial; intra-or extrathecally or both. It has been claimed that antibodies appeared in CSF only after passive transudation from serum.'8 In the present study parallel estimations of anti MBP antibodies was made both in serum and CSF samples. Higher anti MBP antibody values in CSF compared with serum would indicate an intrathecal production site and was found in seven of our 37 patients (19%) . When values were similar in CSF and serum or higher in serum, the site of production may not be accurately 
